Efficient Coating and Sterile Packaging Solutions for Transdermal Patches
Share
How to Achieve Efficient Coating and Sterile Packaging for Patch Products?
With the widespread application of transdermal patches, cooling patches, fever-reducing patches, and therapeutic patches in the pharmaceutical and health sectors, manufacturers face two main challenges in production:
- How to achieve uniform coating of high-viscosity liquids?
- How to balance production efficiency with sterile requirements for final packaging?
1. Efficient Coating: Focus on “Control” and “Adaptability”
Patch formulations are usually high-viscosity systems containing volatile components, requiring precise coating uniformity and thickness control. Common issues include edge build-up, thinning in the middle, and bubble formation. See our pharmaceutical film manufacturing solutions.
Solutions include:
- Adopting dual doctor blade or multi-roll coating systems to enhance leveling ability.
- Integrating automatic tension control systems to keep film tension stable under high temperatures.
- Using enclosed circulation liquid supply systems to avoid air entry and control liquid temperature.
- Utilizing ducted airflow design to create a natural drying gradient, reducing shrinkage after coating.
The MJ150 ODF Solvent-Based / Transdermal Patch Film Making Machine supports continuous coating of viscous patch formulations. For laboratory or small-scale R&D, the MJ150-L ODF Film Coating Machine offers similar precision with flexibility for testing environments.
2. Sterile Packaging: Balancing “Cleanliness” and “Production Pace”
Patch products are mostly for skin contact or external medical use, requiring specific cleanliness levels and ensuring no contaminants enter during packaging.
Recommended solutions include:
- Using enclosed cutting and transfer systems to avoid excessive exposure of the film to air.
- Integrating HEPA-filtered hot air systems to reduce particle concentration in the packaging area.
- Combining vision inspection systems with automatic rejection devices to ensure defective patches are removed before final packaging.
- Installing laminar flow purification or ozone sterilization modules at the discharge point to enhance sterility assurance.
The MJ180 ODF Film Cutting and Packaging Machine can be equipped with cutting, vision inspection, automatic rejection, and edge-sealing modules, making it suited to packaging medical patches and small-dose ODF products.
Conclusion
The patch product market holds huge potential but places higher demands on process integration and cleanliness assurance. Only by ensuring “control” throughout the entire process—from raw liquid coating to final sterile packaging—can companies achieve standardized, efficient, and low-contamination production systems.
HUANGHAI provides end-to-end patch solutions from R&D and pilot testing to commercial-scale production, helping clients reduce trial-and-error costs and quickly enter the health and wellness market.
*Features patented hot-air drying technology (Academician Hou Huimin's patent CN201668734U), delivering higher heating efficiency and uniformity than oven heating.
Related product
MJ150 ODF & Transdermal Patch Film Making Machine
Doctor-blade coating, 0.2–5 m/min running speed, drying from room temperature up to 120 °C.
Frequently Asked Questions
What is the difference between an ODF film and a transdermal patch?
Oral dissolving films (ODF) dissolve on or under the tongue within seconds to minutes; transdermal patches stick to the skin and release the API over hours to days. Both are made by solvent-cast film coating, and the MJ Pro coating platform can be built for either — the application is set before the machine is manufactured.
What output can I expect from Huanghai ODF machines?
MJ150-RD about 1,200 films per hour for formulation screening; MJ150-Lab 8,000–10,000 films per hour for pilot-scale work; MJ150 about 30,000 films per hour (Gen I) for commercial production. For packaging, the MJ180 cuts and packs about 11,900 films per hour (Gen I); the EZ320 (about 9,000 films per hour) is for food-grade films only.
What drying technology is used?
The MJ150 production line uses a patented hot-air parallel-flow drying tunnel (Academician Hou Huimin's patent CN201668734U). The MJ150-RD uses oven drying; the MJ150-Lab uses the same hot-air drying process as the MJ150.
Can Huanghai machines coat multi-formula (striped) films?
Yes. Huanghai's patent CN117323228A covers stripe coating that applies two formulations side by side in one pass, useful for fixed-dose combination films.
Explore Complete ODF & TDDS Manufacturing Solutions
Huanghai offers end-to-end ODF film production lines — from R&D (MJ150-RD / MJ150-Lab) to commercial manufacturing (MJ150). Designed for GMP production and to support 21 CFR Part 11 requirements.
Related guides
- How Pharmaceutical Companies Can Enter the TDDS Field
- Scaling Up Transdermal Patches: Mastering Solvent Handling and Drying Kinetics with the MJ Series
- Expanding ODF Applications: From Oral Films to Transdermal and Cosmetic Patches
Explore all Transdermal Diffusion Instruments →
Compare all ODF manufacturing equipment: model comparison table, pharmacopoeia requirements and FAQ.